{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:57:33Z","timestamp":1791251853722,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.2515\/therapie\/2013022","type":"journal-article","created":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T17:47:14Z","timestamp":1374774434000},"page":"155-161","source":"Crossref","is-referenced-by-count":14,"title":["Cycles de traitement par m\u00e9dicament de substitution aux opiac\u00e9s dans une cohorte de patients suivis 5 ans en m\u00e9decine ambulatoire"],"prefix":"10.1016","volume":"68","author":[{"given":"Julie","family":"Dupouy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Bez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Barsony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Oustric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryse","family":"Lapeyre-Mestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2515\/therapie\/2013022_bb0480","unstructured":"Commission Nationale des stup\u00e9fiants et des psychotropes. Compte-rendu de la r\u00e9union de la 87e r\u00e9union du 18 f\u00e9vrier 2010. http:\/\/ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/1c22bdaa6ccc4499a26635bb67c4bd4b.pdf"},{"issue":"2","key":"10.2515\/therapie\/2013022_bb0485","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"16","author":"Mattick","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"suppl A","key":"10.2515\/therapie\/2013022_bb0490","first-page":"A27","article-title":"Suivi de patients pharmacod\u00e9pendants aux opiac\u00e9s trait\u00e9s par bupr\u00e9norphine haut dosage \u00e0 partir des r\u00e9seaux de soins. \u00c9tude r\u00e9trospective nationale. Exp\u00e9rience de m\u00e9decins g\u00e9n\u00e9ralistes fran\u00e7ais","volume":"151","author":"De Ducla","year":"2000","journal-title":"Ann Med Interne"},{"issue":"3 Suppl","key":"10.2515\/therapie\/2013022_bb0495","first-page":"6","article-title":"Economic and social effects of high-dose buprenorphine substitution therapy. Six-month results","volume":"153","author":"Lavignasse","year":"2002","journal-title":"Ann Med Interne (Paris)"},{"issue":"4","key":"10.2515\/therapie\/2013022_bb0500","first-page":"363","article-title":"Suivi \u00e0 2 ans d\u2019une cohorte de patients sous bupr\u00e9norphine haut dosage. R\u00e9sultats de l\u2019\u00e9tude SPESUB (suivi pharmaco-\u00e9pid\u00e9miologique du Subutex\u00ae en m\u00e9decine de ville)","volume":"48","author":"Duburcq","year":"2000","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"2","key":"10.2515\/therapie\/2013022_bb0505","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00002030-200001280-00010","article-title":"Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group","volume":"14","author":"Moatti","year":"2000","journal-title":"AIDS"},{"key":"10.2515\/therapie\/2013022_bb0510","doi-asserted-by":"crossref","first-page":"c5475","DOI":"10.1136\/bmj.c5475","article-title":"Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database","volume":"341","author":"Cornish","year":"2010","journal-title":"BMJ"},{"key":"10.2515\/therapie\/2013022_bb0515","series-title":"Strat\u00e9gie th\u00e9rapeutique pour les personnes d\u00e9pendantes des opiac\u00e9s : place des traitements de substitution","author":"HAS","year":"2004"},{"issue":"876","key":"10.2515\/therapie\/2013022_bb0520","first-page":"166","article-title":"Bupr\u00e9norphine : faut-il sevrer?","volume":"26","author":"Porcher","year":"2012","journal-title":"La Revue du Praticien M\u00e9decine G\u00e9n\u00e9rale"},{"issue":"1","key":"10.2515\/therapie\/2013022_bb0525","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.drugpo.2010.08.001","article-title":"\u00ab Should I stay or should I go? \u00bb Coming off methadone and buprenorphine treatment","volume":"22","author":"Winstock","year":"2011","journal-title":"Int J Drug Policy"},{"issue":"(18) Suppl 1","key":"10.2515\/therapie\/2013022_bb0530","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0755-4982(04)72375-1","article-title":"Facteurs de risques de rupture pr\u00e9coce de prise en charge lors de l\u2019induction d\u2019un traitement substitutif par bupr\u00e9norphine haut dosage : \u00e9tude chez 1085 d\u00e9pendants aux opiac\u00e9s","volume":"33","author":"Batel","year":"2004","journal-title":"Presse Med"},{"issue":"6","key":"10.2515\/therapie\/2013022_bb0535","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2515\/therapie:2004100","article-title":"Utilisation des bases de donn\u00e9es de l\u2019Assurance maladie par les Centres d\u2019\u00e9valuation et d\u2019information sur la pharmacod\u00e9pendance : exemples, int\u00e9r\u00eats et perspectives","volume":"59","author":"Micallef","year":"2004","journal-title":"Therapie"},{"issue":"3","key":"10.2515\/therapie\/2013022_bb0540","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/pds.1912","article-title":"Pharmacoepidemiological research using French reimbursement databases: yes we can!","volume":"19","author":"Martin-Latry","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"10.2515\/therapie\/2013022_bb0545","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/pds.892","article-title":"Assessment of doctor-shopping for high dosage buprenorphine maintenance treatment in a French region: development of a new method for prescription database","volume":"13","author":"Pradel","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.2515\/therapie\/2013022_bb0550","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/pds.1681","article-title":"Impact of a prescription monitoring program on doctor-shopping for high dosage buprenorphine","volume":"18","author":"Pradel","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.2515\/therapie\/2013022_bb0555","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology http:\/\/www.whocc.no\/atc_ddd_index\/."},{"issue":"11","key":"10.2515\/therapie\/2013022_bb0560","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1525-1497.2005.0228.x","article-title":"Buprenorphine retention in primary care","volume":"20","author":"Stein","year":"2005","journal-title":"J Gen Intern Med"},{"issue":"3","key":"10.2515\/therapie\/2013022_bb0565","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.drugalcdep.2005.01.021","article-title":"Examining the influence of dropouts in a follow-up of maintained opiate users","volume":"79","author":"Encrenaz","year":"2005","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"10.2515\/therapie\/2013022_bb0570","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1017\/S146114570700836X","article-title":"Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study","volume":"11","author":"Soyka","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"10.2515\/therapie\/2013022_bb0575","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/pds.1717","article-title":"Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study","volume":"18","author":"Noize","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716309088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716309088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T11:44:01Z","timestamp":1554291841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716309088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0040595716309088"],"URL":"https:\/\/doi.org\/10.2515\/therapie\/2013022","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}